These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16631966)

  • 41. An animal model for chlorpromazine-induced hyperpigmentation of the skin.
    Forrest IS; Aber RC; Kosek JC; Serra MT
    Proc West Pharmacol Soc; 1969; 12():36-40. PubMed ID: 5812296
    [No Abstract]   [Full Text] [Related]  

  • 42. Imipramine-induced hyperpigmentation: a case report and review of the literature.
    D'Agostino ML; Risser J; Robinson-Bostom L
    J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Abnormal metabolism of melanin associated with pregnancy].
    Kukita A
    Sanfujinka No Jissai; 1970 Jan; 19(1):15-8. PubMed ID: 5467320
    [No Abstract]   [Full Text] [Related]  

  • 44. The clinical profile of children in India with pigmentary anomalies along the lines of Blaschko and central nervous system manifestations.
    Pinheiro A; Mathew MC; Thomas M; Jacob M; Srivastava VM; Cherian R; Raju R; George R
    Pediatr Dermatol; 2007; 24(1):11-7. PubMed ID: 17300642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mustard gas scarring with specific pigmentary, trophic and vascular charactristics (case report, 16-year post-exposure).
    Emadi SN; Hosseini-Khalili A; Soroush MR; Davoodi SM; Aghamiri SS
    Ecotoxicol Environ Saf; 2008 Mar; 69(3):574-6. PubMed ID: 17382390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The biosynthesis of mammalian melanin.
    Pawelek JM; Körner AM
    Am Sci; 1982; 70(2):136-45. PubMed ID: 7091866
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pigmentary changes in oral mucosa].
    Rydosz J
    Czas Stomatol; 1975 Apr; 28(4):423-7. PubMed ID: 165043
    [No Abstract]   [Full Text] [Related]  

  • 49. Hyperpigmentation along tendons in progressive systemic sclerosis.
    Sukenik S; Kleiner-Baumgarten A; Horowitz J
    J Rheumatol; 1986 Apr; 13(2):474-5. PubMed ID: 3723516
    [No Abstract]   [Full Text] [Related]  

  • 50. Adrenocorticotropic hormone, melanocyte-stimulating hormone, and the melanocortin receptors: revisiting the work of Robert Schwyzer: a thirty-year retrospective.
    Dores RM
    Ann N Y Acad Sci; 2009 Apr; 1163():93-100. PubMed ID: 19456331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Factors affecting melanogenesis and methods used for identification of pigmentation disorders].
    Galus R; Zandecki Ł; Sajjad E; Jóźwiak J; Włodarski K
    Pol Merkur Lekarski; 2008 Aug; 25(146):188-91. PubMed ID: 18942345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult-onset dyschromatoses.
    Vachiramon V; Thadanipon K; Rattanakaemakorn P
    Clin Exp Dermatol; 2012 Mar; 37(2):97-103. PubMed ID: 22007646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-pigmentary actions of alpha-melanocyte-stimulating hormone--lessons from the cutaneous melanocortin system.
    Böhm M; Schiller M; Luger TA
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):61-8. PubMed ID: 16914088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flexural pigmentation with multiple lentigines: a new primary pigmentary disorder?
    Ho JC; Chan YC; Giam YC; Ong BH; Kumarasinghe SP
    Br J Dermatol; 2006 Feb; 154(2):382-4. PubMed ID: 16433819
    [No Abstract]   [Full Text] [Related]  

  • 55. Established treatments of skin hypermelanoses.
    Nikolaou V; Stratigos AJ; Katsambas AD
    J Cosmet Dermatol; 2006 Dec; 5(4):303-8. PubMed ID: 17716250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pigmentary patterning as a clinical clue of genetic mosaicism.
    Paller AS
    Arch Dermatol; 1996 Oct; 132(10):1234-5. PubMed ID: 8859037
    [No Abstract]   [Full Text] [Related]  

  • 57. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes.
    Kondo T; Suzuki T; Mitsuhashi Y; Ito S; Kono M; Komine M; Akita H; Tomita Y
    J Dermatol; 2008 Jul; 35(7):395-406. PubMed ID: 18705826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pigmentary disorders in the Mediterranean area.
    El-Mofty MA; Esmat SM; Abdel-Halim MR
    Dermatol Clin; 2007 Jul; 25(3):401-17, x. PubMed ID: 17662906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in melanocyte basic science research.
    Schallreuter KU
    Dermatol Clin; 2007 Jul; 25(3):283-91, vii. PubMed ID: 17662894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.